"osimertinib"

Cancer treatment can get expensive due to the long duration of treatment and the high cost of drugs, especially in cases where the drug needs to be imported as in the case of immunotherapy or targeted therapy.

Taking the drug osimertinib, developed by AstraZeneca, after surgery dramatically reduced the risk of patients dying by 51 per cent